1 We previously demonstrated that 10 mM Mg(2+), 400 mM NaC
2 We previously demonstrated that 24-nt sRNAs are mobile f
3 We previously demonstrated that 48% of patients with pai
4 We previously demonstrated that a class II histone deace
5 We previously demonstrated that a conformationally sensi
6 We previously demonstrated that a high fat diet leads to
7 oximal external region (MPER)-specific BnAb,
we previously demonstrated that a key obstacle to BnAb i
8 We previously demonstrated that a major pathologic respo
9 In nonhuman primates,
we previously demonstrated that a maternal high-fat diet
10 Gram-positive bacteria, including E. faecium
We previously demonstrated that a nonpiliated DeltaempAB
11 We previously demonstrated that a P73G mutation blocks t
12 We previously demonstrated that a P73G mutation that lie
13 f monocyte/macrophage/DC lineages.IMPORTANCE
We previously demonstrated that a pathogenic SIVmac239 v
14 We previously demonstrated that a recombinant A/sw/Texas
15 We previously demonstrated that a recombinant, soluble,
16 ecule, SA-4-1BBL, as the adjuvant of choice,
we previously demonstrated that a single vaccination wit
17 We previously demonstrated that a tumor lysate vaccine/F
18 We previously demonstrated that acquired increased TRPC6
19 We previously demonstrated that actin depolymerization u
20 We previously demonstrated that activated B-Raf/MEK/ERK
21 We previously demonstrated that active Smoothened mutant
22 We previously demonstrated that adding a third DAA to le
23 We previously demonstrated that adenosine A2A receptor (
24 We previously demonstrated that adipocyte-MR overexpress
25 We previously demonstrated that administration of Akkerm
26 We previously demonstrated that AI in mice carrying the
27 We previously demonstrated that Ang II, via its type 1 r
28 We previously demonstrated that angiogenin administratio
29 We previously demonstrated that Arg-Gly-Asp (RGD)-contai
30 We previously demonstrated that ASS1 silencing is contro
31 We previously demonstrated that astrocyte-secreted facto
32 We previously demonstrated that at the mitochondria, mut
33 We previously demonstrated that ATF2 is a nucleocytoplas
34 We previously demonstrated that ATP-independent metallop
35 We previously demonstrated that bacterial flagellar moti
36 In ovarian carcinoma,
we previously demonstrated that Bcl-xL and Mcl-1 coopera
37 We previously demonstrated that beta cells express neuro
38 We previously demonstrated that binding of Grg4 to an Eh
39 We previously demonstrated that biological transcription
40 We previously demonstrated that bone marrow-derived MSCs
41 We previously demonstrated that both human and mouse ath
42 h capacity compacted DNA nanoparticles (NP),
we previously demonstrated that both plasmid and NP form
43 We previously demonstrated that carbon dioxide inhalatio
44 We previously demonstrated that cardiac myosin can use 2
45 We previously demonstrated that CCN2 triggers signaling
46 We previously demonstrated that CD1d-restricted type II
47 We previously demonstrated that CD8(+) T cell responses
48 l tools to differentiate membrane responses,
we previously demonstrated that cell surface mGluR5 trig
49 We previously demonstrated that chronic hyperglycemia ha
50 We previously demonstrated that cNK-lysin and cNK-2, a s
51 We previously demonstrated that co-occurring, weight-dep
52 We previously demonstrated that coagulation factor VIII
53 We previously demonstrated that coinfection with P. mira
54 We previously demonstrated that complement C3b binding a
55 We previously demonstrated that computed tomography (CT)
56 We previously demonstrated that conditional expression o
57 We previously demonstrated that consumption of a Western
58 We previously demonstrated that contextual fear conditio
59 We previously demonstrated that CRF receptor 1 (CRF1) ne
60 We previously demonstrated that crosslinking of HLA I by
61 We previously demonstrated that CS-generated ROS, partic
62 We previously demonstrated that cutaneous epithelium exh
63 We previously demonstrated that cyclosporine A treatment
64 We previously demonstrated that daily practice of a sust
65 We previously demonstrated that DcR3 modulates macrophag
66 We previously demonstrated that dendritic cells (DCs) ex
67 We previously demonstrated that dendrons bearing multipl
68 We previously demonstrated that dexamethasone (Dex) inhi
69 We previously demonstrated that ectodomain residue Asp28
70 We previously demonstrated that ectopic overexpression o
71 We previously demonstrated that EHEC senses acyl-homoser
72 We previously demonstrated that endoglin, a type III tra
73 We previously demonstrated that endothelial NO acts as a
74 We previously demonstrated that Entamoeba histolytica se
75 We previously demonstrated that entinostat enhanced NKG2
76 We previously demonstrated that ERFE messenger RNA expre
77 ing ERK activation are not fully understood,
we previously demonstrated that ERK phosphorylation is e
78 We previously demonstrated that erythropoietin-stimulate
79 We previously demonstrated that ESyt2 interacts specific
80 We previously demonstrated that exposure to DEP was asso
81 We previously demonstrated that expression of CHMP2B(Int
82 We previously demonstrated that female mice lacking GLUT
83 We previously demonstrated that fibroblasts stimulated w
84 the HIV Tat-mediated positive-feedback loop,
we previously demonstrated that fluctuations in viral Ta
85 We previously demonstrated that fungal pathogens can pro
86 We previously demonstrated that galectin (Gal)-8, from t
87 We previously demonstrated that ganglioside GD3 is a maj
88 We previously demonstrated that gB homologs from two alp
89 We previously demonstrated that genetic and/or pharmacol
90 inuous Glucose Monitoring (CGM) murine model
we previously demonstrated that genetic deficiencies of
91 We previously demonstrated that gentamicin produced func
92 We previously demonstrated that global and prefrontal co
93 We previously demonstrated that global deletion of mitoc
94 We previously demonstrated that global inhibition of miR
95 We previously demonstrated that glucose deprivation stim
96 We previously demonstrated that GroEL-GroES enhances the
97 We previously demonstrated that gut Camp expression is u
98 We previously demonstrated that haploinsufficiency of Eg
99 We previously demonstrated that HCMV infection maintains
100 We previously demonstrated that hernia formation is asso
101 We previously demonstrated that heterogeneous genomics d
102 We previously demonstrated that HIC1 can be either acety
103 We previously demonstrated that high reactive oxygen spe
104 We previously demonstrated that HIV replication is conce
105 We previously demonstrated that HIV-1 restriction by MxB
106 We previously demonstrated that host protective expulsio
107 We previously demonstrated that hTRF2 is a double strand
108 We previously demonstrated that hypercapnia suppresses i
109 We previously demonstrated that ICG-001, a small molecul
110 We previously demonstrated that IFN-alphabetagammaR(-/-)
111 We previously demonstrated that IgG-IC directly excited
112 We previously demonstrated that IkappaBalpha markedly in
113 We previously demonstrated that IL1R2 intracellularly ac
114 We previously demonstrated that immunization of lactatin
115 We previously demonstrated that in neutrophils, mammalia
116 We previously demonstrated that individual patients with
117 In a clinical setting,
we previously demonstrated that induction therapy by lym
118 We previously demonstrated that insertion of a foreign g
119 We previously demonstrated that insulin-mediated severe
120 We previously demonstrated that intact heat-killed Strep
121 We previously demonstrated that intact, inactivated Stre
122 We previously demonstrated that interleukin-1alpha (IL-1
123 We previously demonstrated that intermittent access to p
124 We previously demonstrated that intracellular NADPH oxid
125 However,
we previously demonstrated that intracellular replicatio
126 We previously demonstrated that intracytoplasmic sperm i
127 We previously demonstrated that isoflurane targets lymph
128 understood as a Galphaq/11-coupled receptor,
we previously demonstrated that it could couple to and s
129 We previously demonstrated that it is possible to genera
130 We previously demonstrated that knockdown of Max express
131 We previously demonstrated that leucine-rich repeat and
132 We previously demonstrated that LIS1 involvement in the
133 ing conditional knockout strategies of CD28,
we previously demonstrated that loss of CD28 signaling i
134 We previously demonstrated that loss of the retinoblasto
135 We previously demonstrated that Lou/C animals express UC
136 We previously demonstrated that LPS binds to monocytic m
137 We previously demonstrated that lymphocyte function-asso
138 We previously demonstrated that lymphostatin is a putati
139 We previously demonstrated that MBP activates IgE-desens
140 We previously demonstrated that MCP-1 is important for E
141 We previously demonstrated that mesenchymal stem cells (
142 We previously demonstrated that MHV68 LANA (mLANA) is re
143 We previously demonstrated that mice harboring a kinase-
144 We previously demonstrated that micro-RNAs (miRNAs) 132
145 We previously demonstrated that microtubule defects infl
146 We previously demonstrated that mouse TH2 cells selectiv
147 We previously demonstrated that MPN cells become persist
148 We previously demonstrated that mutant mice with selecti
149 We previously demonstrated that mutations in keratin 10
150 We previously demonstrated that mutations predicted to w
151 We previously demonstrated that myeloid lineage-specific
152 We previously demonstrated that myomaker, a skeletal mus
153 We previously demonstrated that Neisseria gonorrhoeae, a
154 We previously demonstrated that neonates of asthmatic mo
155 We previously demonstrated that nerve cell lines selecte
156 We previously demonstrated that network level functional
157 We previously demonstrated that neutrophil extracellular
158 We previously demonstrated that NFAT1 contributes to mel
159 We previously demonstrated that NK cells from HIV-infect
160 We previously demonstrated that non-erythroid alpha-spec
161 We previously demonstrated that one or more products of
162 We previously demonstrated that over-expression of EC4-F
163 We previously demonstrated that overexpression of sarcos
164 We previously demonstrated that (
p)ppGpp was required fo
165 We previously demonstrated that p28 can form an alternat
166 We previously demonstrated that p90 ribosomal S6 kinase
167 We previously demonstrated that palmitoylation of the AM
168 We previously demonstrated that pancreatic intraepitheli
169 We previously demonstrated that pancreatic stellate cell
170 We previously demonstrated that parasympathetic dysfunct
171 We previously demonstrated that parkin ubiquitinates TDP
172 We previously demonstrated that pathogenic SIVmac239 and
173 We previously demonstrated that pathogenic subretinal mo
174 We previously demonstrated that PEAK1-related kinase act
175 We previously demonstrated that PERV in vitro cell tropi
176 We previously demonstrated that PGE(2) synthesis by F. t
177 We previously demonstrated that pharmacological inductio
178 We previously demonstrated that phosphorylation of STIM1
179 We previously demonstrated that Plk4 accumulation is aut
180 We previously demonstrated that PrEP use does not enhanc
181 We previously demonstrated that presenilin and nicastrin
182 We previously demonstrated that prevention of hyperglyce
183 We previously demonstrated that proline content determin
184 We previously demonstrated that promoter-bound factors b
185 We previously demonstrated that protein-specific transfe
186 We previously demonstrated that Q9:VP2.139-specific CD8
187 We previously demonstrated that quinine-stimulated oromo
188 We previously demonstrated that RARalpha2 expression is
189 We previously demonstrated that rat CeA GABAergic transm
190 We previously demonstrated that reduction of spastin lea
191 We previously demonstrated that remodeling requires the
192 We previously demonstrated that retinoic acid (RAR-RXR)
193 We previously demonstrated that Rho kinase 2b (Rock2b) i
194 We previously demonstrated that RICD is impaired in T ce
195 We previously demonstrated that S. aureus MW2 (USA400) b
196 We previously demonstrated that SCD1 is important in lun
197 We previously demonstrated that selective inhibition of
198 We previously demonstrated that ShcA is necessary for th
199 We previously demonstrated that shear force can activate
200 We previously demonstrated that SHP represses the transa
201 We previously demonstrated that simian virus 40 (SV40) l
202 We previously demonstrated that SIRT6, a member of the m
203 We previously demonstrated that SLC30A10 is a cell surfa
204 We previously demonstrated that sodium butyrate is neuro
205 We previously demonstrated that sphingosine kinase 1 (Sp
206 We previously demonstrated that sphingosine, a sphingoli
207 In a rat ALS model (SOD1(G93A) )
we previously demonstrated that spinal respiratory motor
208 We previously demonstrated that sporadic canine colorect
209 We previously demonstrated that sterile protection induc
210 We previously demonstrated that substitution of Asp-362
211 We previously demonstrated that targeted loss of all sel
212 We previously demonstrated that TGF-beta1 suppresses IgE
213 We previously demonstrated that the 5' leader mRNA of th
214 We previously demonstrated that the A673T substitution m
215 We previously demonstrated that the adaptor molecule bre
216 We previously demonstrated that the Alzheimer's disease
217 We previously demonstrated that the ARC1 E3 ligase is re
218 We previously demonstrated that the autoantibodies elici
219 We previously demonstrated that the Bcl-2 homology 4 (BH
220 We previously demonstrated that the cAMP response elemen
221 We previously demonstrated that the CD133(-)/EpCAM(-) he
222 respiratory syncytial virus (RSV) infection,
we previously demonstrated that the CD8(+) T cell immuno
223 We previously demonstrated that the combination of synth
224 We previously demonstrated that the cytosolic Hsc70-SGTA
225 We previously demonstrated that the deubiquitinating enz
226 We previously demonstrated that the dystrophin homologue
227 We previously demonstrated that the E2 proteins of diver
228 8)-linked polyubiquitin degradation signals,
we previously demonstrated that the E6AP/UBE3A ligase ha
229 We previously demonstrated that the efficiency of fluore
230 We previously demonstrated that the enhancer of rudiment
231 We previously demonstrated that the epidermal growth fac
232 We previously demonstrated that the expression of both u
233 We previously demonstrated that the expression of positi
234 We previously demonstrated that the first intron of the
235 We previously demonstrated that the gene encoding h2-cal
236 We previously demonstrated that the GSK inhibitor lithiu
237 We previously demonstrated that the H. pylori cag(+) str
238 We previously demonstrated that the H. pylori cag(+) str
239 We previously demonstrated that the histone deacetylase
240 We previously demonstrated that the histone deacetylase-
241 We previously demonstrated that the histone demethylase
242 We previously demonstrated that the human Dna2 orthologu
243 We previously demonstrated that the human homolog, Las1L
244 We previously demonstrated that the induction of hematop
245 We previously demonstrated that the injection of brain e
246 We previously demonstrated that the kinesin-3 motor KIF1
247 oforms of Ras (Kirsten, Harvey, and Neural),
we previously demonstrated that the Kirsten isoform is k
248 We previously demonstrated that the lipid environment is
249 We previously demonstrated that the marine sponge Hymeni
250 We previously demonstrated that the minor capsid protein
251 We previously demonstrated that the mitogen-activated pr
252 We previously demonstrated that the mTORC1/S6K1 pathway
253 We previously demonstrated that the Mycobacterium tuberc
254 We previously demonstrated that the neuronal guidance cu
255 Using a rat slot machine task (rSMT),
we previously demonstrated that the nonspecific D(2) ago
256 We previously demonstrated that the NTHI Sap transporter
257 We previously demonstrated that the ORF9 gene is essenti
258 We previously demonstrated that the parasite expresses a
259 Using an in vitro approach,
we previously demonstrated that the pattern recognition
260 We previously demonstrated that the positively charged r
261 any RNA-binding proteins are methylated, and
we previously demonstrated that the potent SG-nucleating
262 We previously demonstrated that the presence of HIV-spec
263 We previously demonstrated that the quantitative binding
264 We previously demonstrated that the r(GGGGCC)n RNA forms
265 We previously demonstrated that the small (+/- 10 kDa) v
266 We previously demonstrated that the small GTPase Rab17 r
267 We previously demonstrated that the small interfering RN
268 We previously demonstrated that the sphingolipid metabol
269 We previously demonstrated that the stimulation of CD1b-
270 We previously demonstrated that the synthetic analog of
271 We previously demonstrated that the TM sequences of five
272 We previously demonstrated that the transcription factor
273 We previously demonstrated that the transcription factor
274 We previously demonstrated that the type three secretion
275 We previously demonstrated that the ubiquitin-proteasome
276 We previously demonstrated that the UROS(C73R) mutant pr
277 We previously demonstrated that the yeast Hrq1 helicase
278 Since
we previously demonstrated that these KO mice exhibit a
279 We previously demonstrated that this conjugation leads t
280 We previously demonstrated that this regimen could provi
281 We previously demonstrated that this targeting informati
282 We previously demonstrated that TICs have the capacity t
283 We previously demonstrated that tobacco plants grow phot
284 We previously demonstrated that tolerance induction by a
285 We previously demonstrated that Tpl2 regulates T cell re
286 We previously demonstrated that transient overexpression
287 We previously demonstrated that Tregs can be selectively
288 We previously demonstrated that trogocytosis also occurs
289 We previously demonstrated that TSHR, the target of this
290 We previously demonstrated that two pollen-expressed sPP
291 We previously demonstrated that UL99 interacts with the
292 We previously demonstrated that upregulation of trkB.T1,
293 We previously demonstrated that vaccination of lactating
294 We previously demonstrated that VCP/Cdc48-associated mit
295 We previously demonstrated that virus release is depende
296 We previously demonstrated that WDR5 binds the conserved
297 We previously demonstrated that Wnt16 regulates the somi
298 We previously demonstrated that WNV infection of mice de
299 We previously demonstrated that yeast cells exposed to a
300 by which YopM promotes virulence is unknown,
we previously demonstrated that YopM was required for th